Montreal-based Sectoral Asset Management, a healthcare-focused investment firm, has raised US$96 million in the final close of its New Emerging Medical Opportunities Fund IV. The fund’s limited partners include institutions, family offices, independent asset managers and private banks.
Montreal, May 22, 2020. Sectoral Asset Management is happy to announce the final closing of our New Emerging Medical Opportunities (NEMO) Fund IV at USD96mio.
We are very proud of this milestone, occurring as it does in these difficult times, and wish to thank all of our NEMO III limited partners, who have decided to invest in this fund as well. We also are grateful to the new LPs who have joined our venture. Our LPs are based in North America, Switzerland, Italy, France, Austria, Hong Kong, and Singapore. They represent institutions, family offices, independent asset managers, and private banks.
Between 2009 and December 2019, our NEMO program generated a net return of 2.5X (IRR +44%)*. Sectoral has built a team of eight investment professionals, primarily based in our Montreal office, to source candidates, perform due diligence, and execute deals. We look forward to deploying NEMO IV in the future and are convinced that the current dislocations will create interesting opportunities for astute investors. NEMO IV has already executed three deals, and we plan to use the Fund over a dozen transactions across the medtech and biotech sectors.
Founded in 2000, Sectoral Asset Management is specialized in managing global investment portfolios of the healthcare sector and is in the sector one of the industry leading companies. Sectoral maintains offices in Montreal, Geneva and Hong Kong. The investment approach of the company is based on a primary analysis of company-specific fundamental healthcare data.